Form 4 for SGRY Surgery Partners, Inc.

Accepted 2023-03-06 00:00:00 ET · period of report 2023-01-31 · accession 0001638833-23-000041 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-06	2023-01-31+	SGRY	Burkhalter Danielle	CHRO	S - Sale	$33.60	-880	12.4K	-7%	-$29.6K
M	2023-03-06	2023-01-31+	SGRY	Burkhalter Danielle	CHRO	A - Grant	$33.65	+19.8K	27.6K	+253%	+$665.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-13	S	D	123	$33.88	13,110	D	—	—	(F2) Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 10, 2023.
2	Common	Common Stock	2023-01-31	A	A	740	$54.03	13,233	D	—	—	(F1) Shares issued based on 2022 performance under performance stock unit awards granted to the Reporting Person on March 11, 2022. Shares will vest in two equal annual installments on each of the first two anniversaries of January 31, 2023.
3	Common	Common Stock	2023-01-31	S	D	757	$33.55	12,353	D	—	—	(F3) Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2023.
4	Common	Common Stock	2023-03-02	A	A	3,804	$32.86	31,373	D	—	—	(F5) Shares will vest in three equal annual installments of each of the first three anniversaries of March 2, 2023.
5	Common	Common Stock	2023-03-02	A	A	15,216	$32.86	27,569	D	—	—	(F4) Shares will all vest on the third anniversary of March 2, 2023.